BiVACOR total artificial heart early feasibility study
Part of Heart & circulation clinical trials.
This study tests a new total artificial heart called BiVACOR for people with severe heart failure that cannot be helped by standard pumps. It is designed to keep you alive while you wait for a heart transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe heart failure that a standard left ventricular assist device (LVAD) cannot fix, or you need a pump to support both sides of your heart.
- You are classified as INTERMACS 2 or 3, meaning your heart failure is advanced and you are dependent on IV medications or temporary support.
- You are on the waiting list for a heart transplant.
- You have enough room in your chest for the artificial heart (determined by imaging).
- You do not have a recent stroke, severe organ damage (like kidney or liver failure), or active infection.
- You are not currently on a long-term mechanical heart pump (LVAD or RVAD) or ECMO for more than 7 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new left-ventricular assist device (LVAD) called BrioVAD for people with advanced heart failure who are not getting enough benefit from medicines. If you qualify, the device is implanted to help your heart pump blood.
This trial looks at how well a small heart pump (Corheart 6 LVAS) works over time for people with severe heart failure that hasn't improved with standard treatments. It aims to help those who need extra support to keep their heart pumping.
This registry study checks whether a new venous blood tube used with a heart pump is safe and practical for people whose right heart is failing and who may need a heart transplant. If you qualify, your care team would monitor how the device works over time.
This study follows people who have already received the Corheart 6 heart pump to see how well it works over time. You may qualify if you have severe heart failure that doesn't improve with standard treatments and you got the pump after October 1, 2021.
This study looks at how well continuous-flow heart pumps (VADs) work in people with advanced heart failure. It aims to improve care and outcomes for adults receiving these devices.
This trial tests a new heart pump (BrioVAD) for people with very advanced heart failure. It aims to help those who are not getting better with standard treatments or who need extra support like IV medicines or a balloon pump.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.